维普期刊资源整合服务平台（V6.5）

533篇 您的检索式：作者名="Druker"

选中清除导出查看参考文献查看引证文献引用追踪共27页首页上一页第1页下一页末页 /27 跳转

	题名	作者	年代	出处	被引量
1	Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity显示文摘	Corbin Amie S Agarwal Anupriya Loriaux Marc Cortes Jorge Deininger Michael W Druker Brian J	2011	Journal of Clinical Investigation2011，，1：	3
2	Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies显示文摘	Heinrich MC Blanke CD Druker BJ	2002	J Clin Oncol2002，20，6：	1
3	Chronic myelogenous leukemia显示文摘	Mauro M J Druker B J	2001	Curr Opin Oncol2001，13，：	1
4	Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr2Abl positive cells显示文摘	Druker B J Tamura S Buchdunger E	1996	Nature Med1996，2，5：	1
5	An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase显示文摘	Longnecker R Druker B Thomas M	1991	J Virol1991，65，7：	1
6	Effects of a selective inhibitor of the Abl tyrosinekinase on the growth of Ber-Ahl positive cells 显示文摘	Druker BJ Tamura S Buehdunger E	1996	Nat Med1996，22，2：	1
7	Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia显示文摘	Druker BJ Lydon NB	2000	J Clin Invest2000，105，：	1
8	Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia显示文摘	Lydon NB	2000	J Clin Inst2000，105，：	1
9	The New Meaning of Corporate Social Responsibility 显示文摘	Druker Peter F	1984	California Management1984，26，2：	1
10	Philadelphia chromosome-positive leukemias:from basic mechanisms to molecular therapeutics显示文摘	Kurzrock R Kantarjian HM Druker BJ	2003	Ann Intern Med2003，138，：	1
11	hOCF1 and resistance to imatinib 显示文摘	Crossman LC Druker BJ Deininger WN	2005	Blood2005，106，3：	1
12	Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia显示文摘	Talpaz M Resta D	2001	N Engl J Med2001，344，：	1
13	Plasticity theory strength-differenital(SD) phenomenon and volume expansion in metals and plastics 显示文摘	Druker D C	1973	Met Trans1973，4，：	1
14	Philadelphia chromo- some- positive leukemias:from basic mechanisms to molecular Thera- peutics 显示文摘	Kurzrock R Kantarjian HM Druker BJ	2003	Ann Intern Med2003，138，：	1
15	Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome显示文摘	Sawyers CL Kantarjian H	2001	N Engl J Med2001，344，：	1
16	The development of irnatinib as a therapeutic agent for chronic myeloid leukemia 显示文摘	DEININGER M BUCHDUNGER E DRUKER BJ	2005	Blood2005，105，7：	1
17	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia显示文摘	Druker BJ Guilhot F O'Brien SG		0，，：	1
18	Translation of the Philadelphia chromosome into thera- py for CML显示文摘	Druker BJ	2008	Blood2008，112，13：	1
19	Efficacy and safety of a specific inhibitor of the BCR -ABL tyrosine kinase in chronic myeloid leukemia 显示文摘	Druker B J Talpaz M Resta D J	2001	N En gl J Med2001，344，：	1
20	STI-571:targeting BCR-ABL as therapy for CML显示文摘	Mauro M J Druker B J	2001	Oncologist2001，6，3：	1

返回顶部每页显示：

共27页首页上一页第1页下一页末页 /27 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示